RenalTransplant near Greenwich, CT

Biography: Neal Patel, MD, is a urologic surgeon at New York-Presbyterian Medical Group Queens and an assistant professor of urology at Weill Cornell Medicine.After graduating from George Washington University School of Medicine, Dr. Patel completed his internship and residency at New York-Presbyterian/Weill Cornell Medicine. He then went on to complete a Society of Urologic Oncology (SUO) fellowship at University of California, Los Angeles (UCLA) which focused on the surgical and medical management of complex urologic cancers. In 2020, Dr. Patel was the honored recipient of the Distinguished Housestaff Award by Weill Cornell Medicine for his service and dedication. He has published numerous peer-reviewed articles and is an ad hoc reviewer for several journals.

Biography: Dr. Angela Kadenhe-Chiweshe completed her M.D. degree at the Pennsylvania State University College of Medicine. She entered a categorical general surgery residency at the University of Rochester where her interest in pediatric surgery was solidified. In 2001 she joined the Pediatric Tumor Biology Laboratory as a postdoctoral research fellow under the tutelage of Drs. Jessica Kandel and Darrell Yamashiro. During this time she studied the effects of anti-angiogenic therapy in experimental models of pediatric solid tumors. This work led to key discoveries of how these tumors respond to anti-angiogenic therapy and served as important preclinical data for the Phase II studies for Avastin® (bevacizumab). She also concurrently completed a clinical fellowship in Extra-Corporal Membrane Oxygenation with Dr. Charles Stolar. She went on to complete her general surgery training at Columbia University in 2007, and followed with a clinical fellowship in Pediatric Surgery at the Morgan Stanley Children's' Hospital of New York Presbyterian, in 2009. Dr. Chiweshe joined the faculty of the College of Physicians and Surgeons, Columbia University, as Assistant Professor of Surgery in July 2009 until her departure in June 2018, when she briefly joined the Faculty of the Department of Surgery at Westchester Medical Center. Dr. Chiweshe's clinical interests include all aspects of general and thoracic pediatric surgery: in particular, neonatal anomalies, intestinal rehabilitation, hepatobiliary disease, pediatric cancer and vascular anomalies. Dr. Chiweshe's academic interests lie in the field of clinical and translational research. She served as co-PI of the Pediatric Tumor Biology Lab at Columbia, working alongside her mentor Dr. Yamashiro to elucidate the response of the tumor microenvironment of experimental models of pediatric solid tumors to NOTCH inhibition and high dose radiation. She has received grant funding from various sources, throughout her career, including NIH, Pediatric Cancer Foundation, and other institutional and philanthropic sources. Dr. Kadenhe-Chiweshe is a highly respected mentor and teacher, and has served as a role model to many students, residents, and fellows.Dr. Chiweshe is a Fellow of American College of Surgeons, a member of the American Pediatric Surgical Association, Children's Oncology Group, and the American Academy of Pediatrics. She has been recognized by Castle Connolly as one of "America's Top Doctors".

Biography: Dr. Emond is the Vice Chairman of Surgery at Columbia University. He has over 30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was the co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the way to inducing transplant tolerance in liver patients with the mixed chimerism strategy. As Director of Transplantation at the Columbia University Medical Center Dr. Emond's activities foster clinical excellence and research across all 11 of the solid organ transplant programs at the Medical Center. In recognition of his national and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant Surgeons, the pre-eminent association of a transplant surgery. Contribution to Science Living donor liver transplantation Dr. Emond has spent a substantial portion of his career developing living donor liver transplantation and studying the safety of the procedure in both the donor and recipient. He participated in the first living donor liver transplant in the United States and focused on refining the techniques of performing living donor liver transplants and split liver transplants. He was the national co-chair of the NIH-sponsored Adult-to-Adult Living Donor Liver Transplantation (A2ALL) consortium from 2002 to 2015 to study the safety and outcomes of living donor liver transplants. Hepatic resection/ischemia Dr. Emond developed techniques for surgical resection of liver tumors and studied the effect of ischemia during resection on postoperative liver function. These studies include the outcomes of the extent of hepatectomy, the biochemical response to major hepatectomy and ischemia-reperfusion injury of the liver in rodent models. He has studied the clinical safety of inducing total vascular exclusion to provide a bloodless field during the liver transection. This has applications in both liver cancer and living donor hepatectomies. Hepatocellular carcinoma treatment Dr. Emond has studied many aspects of managing patients with hepatocellular carcinoma. These studies have included characterizing the risk factors for recurrence of disease following transplantation due to comorbidities and tumor characteristics. The research team has also studied the optimal method of preventing tumor growth in patients with HCC on the liver transplant wait list in addition to optimal strategies of liver allocation to optimize outcomes following liver transplantation. These studies have contributed to proposed changes in UNOS exception point allocation for liver transplant candidates with HCC. Pediatric liver transplantation Dr. Emond helped develop the field of pediatric liver transplantation. Contributions to this field include: the use of living donors for pediatric patients; use of auxiliary liver transplants for metabolic diseases; use of partial liver grafts for pediatric patients; and technical modifications that improved outcomes for this patient population. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver